#GS3 #Science&Technology 

  • CSIR’s constituent lab, Institute of Genomics and Integrative Biology (CSIR-IGIB) and TATA Sons signed a MoU for licensing of KNOWHOW for FNCAS9 EDITOR LINKED UNIFORM DETECTION ASSAY (FELUDA) FOR RAPID DIAGNOSIS OF COVID-19. 
  •  A completely indigenous scientific invention, FELUDA for COVID-19 has been designed for mitigating the ongoing COVID-19 situation and cater to mass testing.  
  • Its main advantages are its affordability, relative ease of use and non-dependency on expensive Q-PCR machines. 
  • The license shall include transfer of the knowledge for scaling up the KNOWHOW in the form of a kit that can be deployed for COVID-19 testing on ground as early as end of May. 
Print Friendly and PDF
blog comments powered by Disqus